Form 4 for TECH Bio-Techne
Accepted 2025-08-19 00:00:00 ET · period of report 2025-08-15 · accession 0001062993-25-014709 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-19 | 2025-08-15 | TECH | Hippel James | CFO | F - Tax | $53.60 | -1,926 | 129.9K | -1% | -$103.2K |
| D | 2025-08-19 | 2025-08-15 | TECH | Hippel James | CFO | M - OptEx | $0.00 | +4,010 | 131.8K | +3% | $0 |
| D | 2025-08-19 | 2025-08-15 | TECH | Hippel James | CFO | M - OptEx | $0.00 | -4,010 | 8,021 | -33% | $0 |
| DM | 2025-08-19 | 2025-08-15 | TECH | Hippel James | CFO | A - Grant | $0.00 | +81.8K | 37.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-15 | F | D | 1,926 | $53.60 | 129,883 | D | — | — | |
| 2 | Common | Common Stock | 2025-08-15 | M | A | 4,010 | $0.00 | 131,809 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2025-08-15 | M | D | 4,010 | $0.00 | 8,021 | D | — · — to — | 4,010 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. (F8) 4,010 restricted stock units vest on each of 8/15/2025 and 8/15/2026, and 4,011 restricted stock units vest on 8/15/2027. |
| 4 | Derivative | Performance Restricted Stock Units | 2025-08-15 | A | A | 29,420 | $0.00 | 29,420 | D | — · — to — | 29,420 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. (F11) Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). |
| 5 | Derivative | Restricted Stock Units | 2025-08-15 | A | A | 14,710 | $0.00 | 14,710 | D | — · — to — | 14,710 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. (F12) 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. |
| 6 | Derivative | Stock Options (Right to Buy) | 2025-08-15 | A | A | 37,632 | $0.00 | 37,632 | D | $53.60 · — to 2035-08-15 | 37,632 Common Stock | (F13) Options to purchase 12,544 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. |